innate pharma - Robuta Search

https://www.right2hope.org/directory/80 Innate Pharma - Expanded Access Programs | Right2Hope Innate Pharma on Right2Hope — expanded access programs, compassionate use policies, clinical trial activity, and regulatory compliance for patients. innate pharma expanded access programs https://www.businesswire.com/news/home/20260810719841/en/Innate-Pharma-to-Advance-Lacutamab-Towards-Phase-3-Following-Partnership-With-Sobi-and-Appoints-New-Chief-Medical-Officer Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New... Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that, subject to the closing of its strateg... innate pharma advance towards phase following https://www.syfe.com/stocks/us/ipha Innate Pharma S.A. ADS (IPHA) Stock Price & News | Syfe innate pharma stock price ads ipha news https://endpointarena.com/companies/ipha Innate Pharma S.A. • Endpoint Arena Pipeline assets and company news for Innate Pharma S.A. (IPHA). innate pharma endpoint arena https://www.cancer.fr/personnes-malades/registre-des-essais-cliniques/innate-pharma-remykir-essai-de-phase-2-randomise-evaluant-l-efficacite-et-la-tolerance-de-2-doses-d-un-anticorps-anti-kir-iph2101-chez-des-pat Innate Pharma REMYKIR : Essai de phase 2 randomisé évaluant l'efficacité et la tolérance de 2 doses... innate pharma essai phase doses https://markets.financialcontent.com/worldnow/article/bizwire-2026-4-23-innate-pharma-to-participate-in-the-d-boral-capital-global-conference Innate Pharma to Participate in the D. Boral Capital Global Conference Innate Pharma to Participate in the D. Boral Capital Global Conference innate pharma the d participate boral capital https://markets.financialcontent.com/wedbush/article/bizwire-2026-4-13-number-of-shares-and-voting-rights-of-innate-pharma-as-of-april-9-2026 Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026 Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026 number of voting rights innate pharma shares april https://www.trading-attitude.com/innate-pharma-287-pourcent-depuis-dernier-signal/innate-pharma-287-pourcent innate-pharma-287-pourcent - Trading-Attitude innate pharma pourcent trading attitude https://www.fiercebiotech.com/keyword/innate-pharma Innate Pharma | Fierce Biotech innate pharma fierce biotech https://anantys.com/fr/stock/euronext.paris/IPH INNATE PHARMA (IPH) 1.266 EUR (-4.09%) | Santé & Biotech Euronext / Paris - Anantys Oct 9, 2026 - Performance : momentum 4/100, -24.80% sur 1 an, -48.79% sur 3 ans. Graphique boursier, actualités récentes, actions similaires et suivi communautaire. innate pharma euronext paris iph biotech https://markets.financialcontent.com/worldnow/article/bizwire-2026-4-3-innate-pharma-to-participate-in-the-kempen-life-sciences-conference Innate Pharma to Participate in the Kempen Life Sciences Conference Innate Pharma to Participate in the Kempen Life Sciences Conference innate pharma life sciences participate kempen conference https://www.pharmtech.com/view/astrazeneca-announces-expansion-oncology-collaboration-innate-pharma AstraZeneca Announces Expansion of Oncology Collaboration with Innate Pharma | Pharmaceutical... Oct 14, 2026 - AstraZeneca and Innate Pharma further expand oncology collaboration with a new multi-term agreement. innate pharma astrazeneca announces expansion oncology